Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8737 Cr | ₹872 Cr |
Min Investment | ₹5000 | ₹1000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 10 Jul 2019 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 31% |
Expense Ratio | 1.82 | 2.27 |
Manager | Sailesh Raj Bhan | Dhaval Joshi |
ISIN Code | INF204K01968 | INF209KB1N91 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Month | -0.26% | 1.83% |
6 Month | 10.85% | 11.21% |
1 Year | 4.59% | 2.52% |
3 Year | 23.26% | 23.02% |
5 Year | 18.64% | 16.71% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
6 Month | 4.46% | 6.35% |
1 Year | 7.63% | 9.33% |
3 Year | 22.46% | 22.72% |
5 Year | 18.88% | 18.07% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Year | 17.31% | 25.47% |
3 Year | 20.52% | 16.83% |
5 Year | 20.64% | 22.98% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Standard Deviation | 14.61% | 15.70% |
Sharp | 1.14% | 0.99% |
Beta | 0.90% | 0.97% |
Alpha | 0.72% | -1.60% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Dhaval Joshi |
Total AUM | ₹96086 Cr | ₹361932 Cr |
Funds Managed | 5 | 55 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 1.47 | 5 |
Large Cap | 34.68 | 25.91 |
Mid Cap | 32.06 | 41.99 |
Small Cap | 31.79 | 27.1 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 0.55 | 1.95 |
Healthcare | 99.45 | 97.23 |
Basic Materials | - | 0.82 |
Top Comparisons
Nippon India Pharma Fund-Growth Plan-Growth Option
3Y Returns23.26%
Quant Healthcare Fund Regular - Growth
3Y Returns0%
Kotak Aggressive Hybrid Fund - Growth
3Y Returns15.13%
Mahindra Manulife Aggressive Hybrid Fund - Regular Plan - Growth
3Y Returns16.5%
HDFC Large and Mid Cap Fund - Growth Option
3Y Returns20.42%
INVESCO INDIA LARGE & MID CAP FUND - Growth
3Y Returns25.65%
UTI Banking & PSU Fund- Regular Plan - Growth Option
3Y Returns7.11%
Sundaram Banking and PSU Fund - Regular Plan - Growth
3Y Returns7.28%